Top

Europe Continuous Glucose Monitoring Systems Market - Opportunities and Forecasts, 2014 - 2021)

Category : Medical Devices  | Published Date : Feb-2016 | Pages : 90
enquire Customize Report GET DISCOUNT

Continuous glucose monitoring system (CGMS) is a device that provides with the real-time glucose monitoring in diabetes patients. This technology helps diabetes patients to track their glucose levels round-the-clock. CGMS devices monitor glucose levels at an interval of every 5 minutes. CGMS devices are used along with blood glucose meters to provide supplementary information to facilitate better glucose monitoring and treatment. This technology can be used in diabetes type 1 as well as diabetes type 2 patients. Continuous glucose monitoring assist in stabilizing elevated A1C levels, thereby, reducing the risk of developing long-term diabetic complications. The adoption of CGMS technology is expected to increase, owing to its application in artificial/bionic pancreas.

The Europe CGMS market is estimated to garner $351.7 million by 2021, registering a CAGR of 38.0% during the forecast period. This market is expected to witness significant growth from 2015 to 2021, owing to numerous advantages of CGMS such as minimal invasiveness and real-time blood glucose monitoring. In addition, increasing incidence of diabetes cases in Europe, increasing per capita healthcare expenditure, and growing purchasing power on account of high disposable income of individuals have fueled the market growth. Furthermore, ability of CGMS to provide detailed analysis of blood glucose levels and higher precision as compared to traditional blood glucose monitoring has supplemented the market growth. However, high costs associated with CGMS, lack of adequate reimbursement policies, and limited awareness about CGMS among patients are the major factors hampering the growth of the market.

The report segments the Europe CGMS market on the basis of country and components. Based on country, the market is segmented into the U.K., France, Germany, Norway, Sweden, Denmark, Finland and Other Europe. Presently, the Germany leads the Europe CGMS market, owing to its large diabetes patient pool and high healthcare expenditure. The components of the CGMS comprise sensors, transmitters & receivers, and integrated insulin pumps. The sensors segment dominates the market, as the sensor loses its sensitivity after using if for about 5 to 7 days, which requires frequent requirement.

Europe CGMS market has presence of numerous manufacturers that are adopting partnership and collaboration as their strategy to commercialize CGMS. For instance, Senseonics and Rubin Medical have adopted the collaboration strategy to commercialize their CGMS products in Denmark and Sweden. The companies profiled in the report include Medtronic Inc., Dexcom, Inc., Abbott Diabetic care, Senseonics Incorporated, Insulet Corporation, Echo therapeutics, Glysens Inc. and Animas Corporation,

KEY BENEFITS FOR STAKEHOLDERS:

  • This report provides an in-depth analysis of the current and emerging market trends and dynamics in the Europe CGMS market.
  • The European CGMS market is analyzed based on countries such as the U.K., France, Germany, Norway, Sweden, Denmark, Finland, and Other Europe.
  • An in-depth analysis of key strategies adopted by key manufacturers helps in understanding competitive scenario.
  • This report provides an exhaustive analysis of the factors that drive and restrict the growth of the Europe CGMS market.
  • The reimbursement scenario of CGMS devices has been provided in this report.

EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET KEY SEGMENTS:

BY COUNTRY

  • U.K.
  • France
  • Germany
  • Norway
  • Sweden
  • Denmark
  • Finland
  • Other Europe

BY COMPONENTS

  • Sensors
  • Transmitters & receivers
  • Integrated insulin pumps

CHAPTER 1 INTRODUCTION

1.1 Market definition and scope
1.2 Research methodology

1.2.1 Secondary research
1.2.2 Primary Research
1.2.3 Analyst Tools and Models

CHAPTER 2 EXECUTIVE SUMMARY

CHAPTER 3 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)

3.1 Overview

3.1.1 Market size and forecast

CHAPTER 4 U.K. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)

4.1 Key market trends
4.2 Key growth factors and opportunities
4.3 Market size and forecast
4.4 Reimbursement scenario

CHAPTER 5 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)

5.1 Key market trends
5.2 Key growth factors and opportunities
5.3 Market size and forecast
5.4 Reimbursement scenario

CHAPTER 6 FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)

6.1 Key market trends
6.2 Key growth factors and opportunities
6.3 Market size and forecast
6.4 Reimbursement scenario

CHAPTER 7 NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)

7.1 Key market trends
7.2 Key growth factors and opportunities
7.3 Market size and forecast
7.4 Reimbursement scenario

CHAPTER 8 SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021, ($THOUSANDS)

8.1 Key market trends
8.2 Key growth factors and opportunities
8.3 Market size and forecast
8.4 Reimbursement scenario

CHAPTER 9 DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021, ($THOUSANDS)

9.1 Key market trends
9.2 Key growth factors and opportunities
9.3 Market size and forecast
9.4 Reimbursement scenario

CHAPTER 10 FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021, ($THOUSANDS)

10.1 Key market trends
10.2 Key growth factors and opportunities
10.3 Market size and forecast
10.4 Reimbursement scenario

CHAPTER 11 OTHER EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021, ($THOUSANDS)

11.1 Key market trends
11.2 Key growth factors and opportunities
11.3 Market Size and Forecast
11.4 Reimbursement Scenario

11.4.1 Israel
11.4.2 The Netherlands
11.4.3 Slovenia
11.4.4 Spain
11.4.5 Switzerland

CHAPTER 12 COMPANY PROFILES

12.1 Medtronic Inc.

12.1.1 Company overview
12.1.2 Company snapshot
12.1.3 Business performance
12.1.4 Strategic moves and developments

12.1.4.1 Principal strategies: product launch
12.1.4.2 Secondary strategies: approval
12.1.4.3 Other strategies: strategic alliance and collaboration

12.1.5 SWOT analysis of Medtronic Inc.

12.2 Dexcom Inc.

12.2.1 Company overview
12.2.2 Company snapshot
12.2.3 Business performance
12.2.4 Strategic moves and developments

12.2.4.1 Principal strategies: agreement/partnership
12.2.4.2 Secondary strategies: approval
12.2.4.3 Other strategies: acquisition

12.2.5 SWOT analysis of Dexcom

12.3 Abbott Diabetic Care (Abbott Laboratories)

12.3.1 Company overview
12.3.2 Company snapshot
12.3.3 Business performance
12.3.4 Strategic moves and developments
12.3.5 SWOT analysis of Abbott diabetic care

12.4 Senseonics, Incorporated

12.4.1 Company overview
12.4.2 Company snapshot
12.4.3 Strategic moves and development
12.4.4 SWOT analysis of Senseonics

12.5 Animas Corporation

12.5.1 Company overview
12.5.2 Company snapshot
12.5.3 Strategic moves and developments
12.5.4 SWOT analysis of Animas Corporation

12.6 Insulet Corporation

12.6.1 Company overview
12.6.2 Company snapshot
12.6.3 Strategic moves and developments
12.6.4 SWOT analysis of INSULET Corporation

12.7 Echo Therapeutics

12.7.1 Company Overview
12.7.2 Company snapshot
12.7.3 Strategic moves and development
12.7.4 SWOT analysis of Echo Therapeutics

12.8 Glysens Inc.

12.8.1 Company overview
12.8.2 Company snapshot
12.8.3 Strategic moves and developments
12.8.4 SWOT analysis of Glysens Inc.

List of Tables

TABLE 1 EUROPE CGMS MARKET BY COUNTRY, 2014-2021, ($THOUSANDS)
TABLE 2 U.K. CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)
TABLE 3 GERMANY CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)
TABLE 4 FRANCE CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)
TABLE 5 NORWAY CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)
TABLE 6 SWEDEN CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)
TABLE 7 DENMARK CGMS MARKET BY COMPONENTS, 2014-2021 ($THOUSANDS)
TABLE 8 FINLAND CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)
TABLE 9 OTHER EUROPE CGMS MARKET BY COMPONENTS, 2014-2021, ($THOUSANDS)
TABLE 10 MEDTRONIC BUSINESS SNAPSHOT
TABLE 11 DEXCOM INC. BUSINESS SNAPSHOT
TABLE 12 ABBOTT DIABETIC CAREBUSINESS SNAPSHOT
TABLE 13 SENSEONICS SNAPSHOT
TABLE 14 ANIMAS CORPORATION BUSINESS SNAPSHOT
TABLE 15 INSULET CORPORATION BUSINESS SNAPSHOT
TABLE 16 GLYSENS INC. BUSINESS SNAPSHOT

List of Figures

FIG. 1 MEDTRONIC REVENUE BY BUSINESS UNITS (2014)
FIG. 2 MEDTRONIC REVENUE BY GEOGRAPHY (2014)
FIG. 3 SWOT ANALYSIS OF MEDTRONIC
FIG. 4 SWOT ANALYSIS OF DEXCOM INC.
FIG. 5 REVENUE BY BUSINESS SEGMENT (2014)
FIG. 6 SWOT ANALYSIS OF ABBOTT DIABETIC CARE
FIG. 7 SWOT ANALYSIS OF SENSEONICS
FIG. 8 SWOT ANALYSIS OF ANIMAS CORPORATION
FIG. 9 SWOT ANALYSIS OF INSULET CORPORATION
FIG. 10 SWOT ANALYSIS OF ECHO THERAPEUTICS
FIG. 11 SWOT ANALASIS OF GLYSEN INCORPORATED

...
Publisher Name : Allied Market Research

SIMILAR MARKET STUDIES

Please Select Format
Single User :- US $ 3390
Five User:- US $ 4227
Enterprise User:- US $ 5910
Data Pack :- US $ 2490

NEED MORE INFORMATION
Contact us
Call us +1-971-202-1575
--- or ---
help@bigmarketresearch.com
WHY BIG MARKET RESEARCH
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.
Top